ResearcherHiroshima UniversityNo recent work listed
Taijiro Sueda
Matched on OpenAlex author ID A5111832277. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper
Papers 8
- Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-020-09278-9↗
- Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by the resectability status. Last author DOI 10.1002/jso.25066↗
- The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuva… Last author DOI 10.1016/j.pan.2017.12.014↗
- A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma. Last author DOI 10.1007/s00280-017-3274-0↗
- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. Co-author DOI 10.1038/bjc.2016.175↗
- Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-016-5120-8↗
- An Increased Number of Perineural Invasions Is Independently Associated With Poor Survival of Patients With Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000000413↗
- Prognostic impact of dihydropyrimidine dehydrogenase expression on pancreatic adenocarcinoma patients treated with S-1-based adjuvant chemotherapy after surgic… Last author DOI 10.1002/jso.21955↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshiaki Murakami · 8 shared papers, 2011–2021 · strength 0.58
- Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
- Paper Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by… DOI 10.1002/jso.25066↗
- Paper The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic d… DOI 10.1016/j.pan.2017.12.014↗
- Naru Kondo · 8 shared papers, 2011–2021 · strength 0.58
- Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
- Paper Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by… DOI 10.1002/jso.25066↗
- Paper The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic d… DOI 10.1016/j.pan.2017.12.014↗
- Kenichiro Uemura · 8 shared papers, 2011–2021 · strength 0.58
- Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
- Paper Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by… DOI 10.1002/jso.25066↗
- Paper The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic d… DOI 10.1016/j.pan.2017.12.014↗
- Shin’ya Takahashi · 5 shared papers, 2016–2021 · strength 0.43
- Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
- Paper Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by… DOI 10.1002/jso.25066↗
- Paper The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic d… DOI 10.1016/j.pan.2017.12.014↗
- Kenjiro Okada · 2 shared papers, 2018–2021 · strength 0.22
- Paper Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-020-09278-9↗
- Paper Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by… DOI 10.1002/jso.25066↗
- Eiso Hiyama · 2 shared papers, 2016–2021 · strength 0.19
- Takuro Yamaguchi · 1 shared paper, 2021 · strength 0.13
- Takeshi Sudo · 2 shared papers, 2011–2017 · strength 0.10
- Paper A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally … DOI 10.1007/s00280-017-3274-0↗
- Paper Prognostic impact of dihydropyrimidine dehydrogenase expression on pancreatic adenocarcinoma patients treated with S-1-… DOI 10.1002/jso.21955↗
- Ryuta Shintakuya · 1 shared paper, 2018 · strength 0.09
- Naoto Hadano · 1 shared paper, 2016 · strength 0.06
- Toshiaki Komo · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.